<DOC>
	<DOCNO>NCT00260377</DOCNO>
	<brief_summary>Aspirin prove drug prevent vein graft closure improve clinical outcome coronary artery bypass surgery . It appear effective prescribed early first 48 hr . operation without increase incidence bleeding complication . exact effective dose know .</brief_summary>
	<brief_title>Aspirin Resistance Following Coronary Bypass Surgery</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Patients undergo Coronary artery bypass surgery Patients sign Informed Consent Form Concomitant valve surgery carotid surgery offpump surgery Need anticoagulation therapy reason Another antiplatelet medication least 7 day prior surgery Contraindication aspirin treatment Thrombocytopenia / thrombocytopathia NSAIDs treatment chronic medical condition Reluctance participate study</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Aspirin treatment</keyword>
	<keyword>Aspirin resistance</keyword>
	<keyword>Coronary bypass surgery</keyword>
</DOC>